IVSS — Applied Finance IVS US SMID ETF

Is IVSS overbought or oversold? Here is the current MarketMoodz read.

Oversold As of August 19, 2026

Applied Finance IVS US SMID ETF (IVSS) currently reads Oversold on the MarketMoodz overbought/oversold meter, as of August 19, 2026. The stock last closed at $30.50. The rating moved from Overbought to Oversold on August 19, 2026.

AI analysis

Applied Finance IVS US SMID ETF (IVSS) offers targeted exposure to the US small- and mid-cap segment with a fundamentals-oriented selection methodology. Performance will be driven primarily by cyclical earnings momentum, sector composition, and market liquidity conditions. Investors should view near-term returns as dependent on macro follow-through and specific factor performance.

Key factors

  • Exposure to US small- and mid-cap equities which historically deliver stronger earnings growth during cyclical expansions
  • Current market tone shows mild risk-on flows and rotation into cyclicals, supportive for SMID segment
  • Fundamentals-driven, systematic selection approach (Applied Finance) can favor companies with relative valuation and quality characteristics
  • ETF structure provides intraday liquidity, diversification across SMID names and simpler portfolio access versus individual stocks
  • Potential for alpha if small/mid caps benefit from improving macro data and stable policy expectations

Risks

  • Higher volatility and sensitivity to rate moves and economic slowdowns compared with large-cap benchmarks
  • Liquidity and market-depth issues in some underlying SMID constituents can amplify drawdowns
  • Concentration or sector biases in the underlying portfolio could underperform broader market rotations
  • Tracking error or strategy underperformance relative to peers or benchmarks if factor tilts underdeliver
  • Limited recent public social/filing signals reduce near-term company-specific catalysts or transparency

See today's live rating, score and targets

Members see the live hourly rating for IVSS — the numeric AI score plus targets and entry zones — while this public page updates nightly.

Start the 14-day trial

This page is for informational purposes only and is not investment, financial, tax, or legal advice. Ratings and research outputs can be wrong, incomplete, or stale. Past performance does not guarantee future results. Always do your own research and consider consulting a qualified professional.